Management of bladder endometriosis with combined transurethral and laparoscopic approach. Follow-up of pain control, quality of life, and sexual function at 12 months after surgery

A Pontis, Pontis A, Nappi L, L Nappi, Sedda F, F Sedda, F Multinu, Multinu F, Litta P, P. Litta, S Angioni, Stefano Angioni
Clinical and experimental obstetrics & gynecology · 2016 · doi:10.12891/ceog3367.2016 · PMID:29944233
other OA: bronze public-domain-us
🔓 Open OA copy Full text JSON View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This prospective study evaluated a combined transurethral and laparoscopic approach for bladder endometriosis, finding significant improvements in lower urinary tract symptoms, quality of life, and sexual function one year post-surgery with no complications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-09 · read from full text ⓘ

This prospective observational study followed 16 women with symptomatic bladder endometriosis treated at three Italian university hospitals using a combined transurethral and laparoscopic approach to excise bladder nodules. Lower urinary tract symptom intensity was measured with VAS at baseline and at 1, 6, and 12 months, while quality of life (SF-36) and sexual function (FSFI) were collected preoperatively and at one year. VAS scores were significantly lower at 1, 6, and 12 months versus presurgery (p < 0.001), and quality of life and sexual function improved at one year across patients; no intraoperative or postoperative complications or conversion to laparotomy were reported. This paper is centrally about endometriosis — it evaluates 12-month outcomes after combined transurethral and laparoscopic management of bladder endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

To describe the pre-surgical and post-surgical outcomes at one year in terms of recurrence of lower urinary tract symptoms, quality of life, and sexual function of a transurethral and laparoscopic combined approach in the treatment of bladder endometriosis. The au- thors performed a prospective observational study of 16 women affected by symptomatic bladder endometriosis at the University Hos- pitals of Cagliari, Padua, and Foggia. In all patients bladder nodule was excised with a transurethral and laparoscopic combined approach technique. Intensity of lower urinary tract symptoms (VAS score) were assessed pre- and post-operatively at one, six, and 12 months after surgery; quality of life (SF-36) and sexual functions (FSFI) were collected preoperatively and one year postoperatively. Operative time was 120.18 ± 15.77 minutes and mean blood loss was 65.12 ± 44.74. No intraoperative and postoperative complications and conversion laparotomy occurred. Intensity of lower urinary tract symptoms evaluated with VAS score were significantly lower after one, six, and 12 months postsurgery vs. presurgery (p < 0.001). The authors observed a significantly improvement in the quality of life and sexual functions in all patients at one year after surgery. This surgical approach is safe and simple in the treatment of bladder en- dometriosis, with low risks and optimal resolution of symptoms, and improvement of quality of life and sexual function.
Full text 2,320 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

To describe the pre-surgical and post-surgical outcomes at one year in terms of recurrence of lower urinary tract symptoms, quality of life, and sexual function of a transurethral and laparoscopic combined approach in the treatment of bladder endometriosis. The authors performed a prospective observational study of 16 women affected by symptomatic bladder endometriosis at the University Hospitals of Cagliari, Padua, and Foggia. In all patients bladder nodule was excised with a transurethral and laparoscopic combined approach technique. Intensity of lower urinary tract symptoms (VAS score) were assessed pre- and post-operatively at one, six, and 12 months after surgery; quality of life (SF-36) and sexual functions (FSFI) were collected preoperatively and one year postoperatively. Operative time was 120.18 ± 15.77 minutes and mean blood loss was 65.12 ± 44.74. No intraoperative and postoperative complications and conversion laparotomy occurred. Intensity of lower urinary tract symptoms evaluated with VAS score were significantly lower after one, six, and 12 months postsurgery vs. presurgery (p < 0.001). The authors observed a significantly improvement in the quality of life and sexual functions in all patients at one year after surgery. This surgical approach is safe and simple in the treatment of bladder endometriosis, with low risks and optimal resolution of symptoms, and improvement of quality of life and sexual function.

Keywords

- Bladder endometriosis - Quality of life - Sexual function - Pain control

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Outcome instruments

VAS-pain

Condition tags

dyspareuniaendometriosisbladder_endometriosis

MeSH descriptors

Cystoscopy Endometriosis Laparoscopy Sexual Health Urinary Bladder Diseases Adult Conversion to Open Surgery Cystoscopy Dyspareunia Endometriosis Female Follow-Up Studies Humans Laparoscopy Middle Aged Operative Time Pain Pain Management Postoperative Complications Postoperative Complications

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-19T06:08:28.815611+00:00
pubmed
last seen: 2026-05-13T22:21:19.813018+00:00
unpaywall
last seen: 2026-05-16T02:00:00.672124+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine